Comments: NJ A4520 | 2022-2023 | Regular Session

Bill Title: Prohibits excessive charges for drugs developed by publicly funded research.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced - Dead) 2022-09-22 - Introduced, Referred to Assembly Consumer Affairs Committee [A4520 Detail]

Text: Latest bill text (Introduced) [HTML]

PolitiCorps Conversations

Start PolitiCorps Debate
TitlePolitiCorpsAccessCommentsViewsLast Post
There are no visible public or private PolitiCorps discussions concerning the 2022 New Jersey A4520 at this time.

Social Comments on NJ A4520

feedback